Company profile for The Valens Company

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The Valens Company (TSX:VLNS) (OTCQX:VLNCF) is a multi-licensed, vertically-integrated cannabis company focused on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and white-label product development. The Valens Company is the largest third...
The Valens Company (TSX:VLNS) (OTCQX:VLNCF) is a multi-licensed, vertically-integrated cannabis company focused on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and white-label product development. The Valens Company is the largest third-party extraction Company in Canada with an annual capacity of 425,000 kg of dried cannabis and hemp biomass at our purpose-built facility in Kelowna, British Columbia which is in the process of becoming European Union

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
230 Carion Road Kelowna, BC V4V 2K5
Telephone
Telephone
1 (778) 755-0052
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/the-valens-company-granted-additional-180-calendar-day-grace-period-by-nasdaq-to-regain-compliance-with-minimum-bid-price-rule-301702320.html

PRNEWSWIRE
13 Dec 2022

https://www.prnewswire.com/news-releases/valens-shareholders-vote-in-favour-of-the-arrangement-with-sndl-301689513.html

PRNEWSWIRE
29 Nov 2022

https://www.prnewswire.com/news-releases/both-leading-independent-proxy-advisors-recommend-shareholders-of-the-valens-company-inc-vote-for-the-proposed-arrangement-with-sndl-inc-301684914.html

PRNEWSWIRE
22 Nov 2022

https://www.prnewswire.com/news-releases/valens-secures-sales-licence-for-greater-toronto-area-beverage-facility-301666851.html

PRNEWSWIRE
02 Nov 2022

https://www.prnewswire.com/news-releases/the-valens-company-announces-mailing-and-filing-of-circular-for-special-meeting-of-shareholders-to-approve-arrangement-with-sndl-inc-301661826.html

PRNEWSWIRE
27 Oct 2022

https://www.prnewswire.com/news-releases/the-valens-company-reports-third-quarter-fiscal-2022-financial-results-301648452.html

PRNEWSWIRE
13 Oct 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty